Curis Lifesciences (NSE:CURIS) Forward Dividend Yield %: 0.00% (As of Jul. 06, 2026)


NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
30 GF Score
Price ₹99.80
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences Forward Dividend Yield %?

Curis Lifesciences NSE:CURIS +0.40% 30 Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 507 Drug Manufacturers companies, Curis Lifesciences ranks worse than 197238.46% on this metric.

As of today (2026-07-06), the Forward Annual Dividend Yield of Curis Lifesciences is 0.00%.

As of today (2026-07-06), the Trailing Annual Dividend Yield of Curis Lifesciences is 0.00%.

NSE:CURIS's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.03
* Ranked among companies with meaningful Forward Dividend Yield % only.

Curis Lifesciences's Dividends per Share for the six months ended in Mar. 2026 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Curis Lifesciences  (NSE:CURIS) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Curis Lifesciences Forward Dividend Yield % Related Terms

NSE:CURIS vs ZTS, UTHR: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curis Lifesciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curis Lifesciences Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curis Lifesciences's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Curis Lifesciences's Forward Dividend Yield % falls into.


NSE:CURIS
30GF Score
Curis Lifesciences Ltd NSE:CURIS
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Curis Lifesciences (NSE:CURIS) has a Forward Dividend Yield % of 0.00% as of Jul. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Curis Lifesciences and its competitors. According to the industry distribution chart, Curis Lifesciences ranks #999999 out of 507 companies in the Drug Manufacturers industry.
Is Curis Lifesciences' Forward Dividend Yield % too high?
Curis Lifesciences' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Curis Lifesciences ranks #999999 out of 507 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Curis Lifesciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curis Lifesciences ranks #999999 out of 507 companies for Forward Dividend Yield %. This places Curis Lifesciences in the lower half of its industry. The industry median Forward Dividend Yield % is 2.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.03, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Curis Lifesciences and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curis Lifesciences's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Curis Lifesciences' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
30GF Score

Get the complete analysis for NSE:CURIS

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹99.80
Price